Role endomyokardiální biopsie v současnosti

Bronislav Janek

Interv Akut Kardiol. 2013;12(3):112-114  

Šest set slov

MUDr. Radkin Honzák, CSc.

Interv Akut Kardiol. 2013;12(3):107  

Long-term monitoring of heart rhythm disorders in patients after transcatheter closure of secundum atrial septal

Martina Miklošová, Petr Pařízek, Jiří Duda, Luděk Haman, Josef Šťásek, Veronika Bulková, Jan Vojáček

Interv Akut Kardiol. 2013;12(3):116-118  

defect and patent foramen ovale – pilot project Introduction: Transcatheter closure is the standard of care for secundum atrial septal defect (ASD II) and patent foramen ovale (PFO). In the literature, there is a lot of information regarding the incidence of arrhythmias related with these two procedures, but on the other hand there is very little known about the contribution of these methods for long-term monitoring of ECG. Goal: To monitor heart rhythm and ascertain the incidence of arrhythmias in patients after percutaneous closure of ASD II and PFO with the Amplatzer occluder, using methods for long-term monitoring of ECG. Methods:...

Sutureless aortic bioprotheses - initial experience with Sorin Perceval S prosthesis

Aleš Mokráček, Júlia Čanádyová, Vojtěch Kurfirst, Martin Rezler

Interv Akut Kardiol. 2013;12(3):121-123  

Sutureless aortic bioprostheses are a new generation of bioprostheses constructed for treatment of aortic stenosis. Their construction is focused on safety of a procedure and hemodynamic parameters. They are compatible with minimally invasive surgery. In our paper we present a first experience with prosthesis Perceval S, Sorin.

Catheter ablation in treating arrhythmias in patients with congenital heart defect

Petr Peichl, Josef Kautzner

Interv Akut Kardiol. 2013;12(3):124-129  

Arrhythmias are the leading cause of morbidity and mortality in adult patients with congenital heart defect. Patients in this group typically develop incisional tachycardias. They are caused by reentry circulating around scar tissue or prosthetic material following a surgical procedure. Most commonly, intra-atrial reentry occurs, in which the impulse circulates around a right atriotomy scar. In the case of complex heart defects, the location of the reentry circuit is individual and, given an abnormal diversion of blood flow, catheter access to the heart chambers may be difficult. The other types of arrhythmias, such as focal tachycardias, accessory...

Intraaortic balloon counterpulsation in clinical cardiology

Karel Kopřiva, Petr Ošťádal, Martin Mates, Petr Neužil

Interv Akut Kardiol. 2013;12(3):130-134  

Intraaortic balloon counterpulsation (IABC) is the most common method of mechanical circulatory support and it has been used in clinical settings for more than four decades. The widespread use of IABC was based mainly on its favourable hemodynamic effects and observational data. The majority of studies analysing the effect of IABC in ST-elevation myocardial infarction (STEMI) without cardiogenic shock did not show an efficacy benefit. The recent randomised CRISP AMI trial could not demonstrate a reduction of infarct size in patients with STEMI without shock and IABC placement as adjunctive treatment to primary percutaneous coronary intervention...

Complications of catheter ablation for cardiac arrhythmias

Bashar Aldhoon, Josef Kautzner

Interv Akut Kardiol. 2013;12(3):135-140  

Catheter ablation has established itself as a first-line therapy for the majority of supraventricular and many ventricular tachyarrhythmias. Long-term success of catheter ablation of different types of arrhythmias is impressively high and often exceeds 95 %. On the other hand, catheter ablation may be associated with complications, given by the invasive nature of catheterization procedure in general (eg. vascular complications) or related to the type of performed procedure (eg. atrioventricular block during atrioventricular node modification). In ventricular arrhythmias associated with structural heart disease, higher complication rate reflects...

Coronary and mortality risks in novel oral antithrombotic agents: a meta-analysis of large randomized trials

Koon-Hou Mak

Interv Akut Kardiol. 2013;12(3):142-148  

Aim: Oral direct thrombin inhibitors and anti-Xa inhibitors have been shown to be effective in preventing and treating venous thromboembolism as well as in preventing embolic events in atrial fibrillation. Recent studies have shown that dabigatran administration may be associated with increased rates of myocardial infarction (MI). The risk of coronary events with other agents has not yet been determined precisely. The aim of this study is to ascertain the risk of coronary events in association with the use of four novel antithrombotic agents. Study design: Meta-analysis of published comparisons of different methods of treatment. Sources of data...

Huge left ventricular pseudoaneurysm diagnosed with cardiac computed tomography imaging

Markéta Vančurová, Jozef Jakabčin, Andrej Kupec, Jana Bednářová

Interv Akut Kardiol. 2013;12(3):154-156  

Pseudoaneurysm of the left ventricle is relatively rare complication of myocardial infarction. The risk of the rupture is much higher than in the true left ventricular aneurysm. The early diagnosis and differentiation of these two clinical comlications is crucial for the best decision to treat surgically. This text summarises knowledge of the pathogenesis, focusing on the possibility to achieve the true diagnosis early and noninvasively, including cardiac computed tomography and cardiac magnetic resonance. We present the clinical case of 79-year-old woman with pseudoaneurysm of the left ventricle as a late complication of an old myocardial...

Spontaneous rupture of giant right coronary artery aneurysm as a cause of cardiac tamponade

Jana Hanuliaková, Bronislav Janek, Peter Telekes, David Horák, Tomáš Roubíček, Zdeněk Velička, Rostislav Polášek

Interv Akut Kardiol. 2013;12(3):159-162  

Spontaneous rupture of coronary artery aneurysm is a very rare complication diagnosed mostly post mortem as a cause of sudden cardiac death. Authors present a case of 66 year old man with spontaneous rupture of giant coronary artery aneurysm presenting with cardiogenic shock due to cardiac tamponade.

Urapidil, a first-choice drug for severe hypertensive states

Tomáš Janota, Tomáš Zelinka

Interv Akut Kardiol. 2013;12(3):150-152  

Urapidil is a peripheral α-blocker as well as a weak central 5-hydroxytryptamine receptor agonist. It reduces peripheral vascular resistance without causing significant reflex tachycardia. It is very well tolerated. From the perspective of an intensive cardiologist, the intravenous form is important. Having a rapid, almost immediate onset of action and a relatively rapid cessation of action, urapidil is designed for the management of hypertensive emergencies. Given its high efficacy and parenteral administration, it is certainly suitable for all conditions with a more severe resistant hypertension where enteral treatment is not possible,...